These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25959998)

  • 61. Emdogain in regenerative periodontal therapy. A review of the literature.
    Sculean A; Windisch P; Döri F; Keglevich T; Molnár B; Gera I
    Fogorv Sz; 2007 Oct; 100(5):220-32, 211-9. PubMed ID: 18078142
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [The use of enamel matrix derivative in periodontal therapy].
    Venezia E; Goldstein M; Schwartz Z
    Refuat Hapeh Vehashinayim (1993); 2002 Jul; 19(3):19-34, 88. PubMed ID: 12242763
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Recombinant human bone morphogenetic protein-2 promotes wound healing in rat periodontal fenestration defects.
    King GN; King N; Cruchley AT; Wozney JM; Hughes FJ
    J Dent Res; 1997 Aug; 76(8):1460-70. PubMed ID: 9240382
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Enamel matrix derivative in the treatment of human intrabony osseous defects.
    Okuda K; Momose M; Miyazaki A; Murata M; Yokoyama S; Yonezawa Y; Wolff LF; Yoshie H
    J Periodontol; 2000 Dec; 71(12):1821-8. PubMed ID: 11156038
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of enamel matrix derivative on mineralized tissue formation during bone wound healing in rat parietal bone defects.
    Sawae Y; Sahara T; Kawana F; Sasaki T
    J Electron Microsc (Tokyo); 2002; 51(6):413-23. PubMed ID: 12630784
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Histologic evaluation of periodontal healing in humans following regenerative therapy with enamel matrix derivative. A 10-case series.
    Yukna RA; Mellonig JT
    J Periodontol; 2000 May; 71(5):752-9. PubMed ID: 10872956
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of the adjunctive effect of platelet-rich fibrin to enamel matrix derivative in the treatment of intrabony defects. Six-month results of a randomized, split-mouth, controlled clinical study.
    Aydemir Turkal H; Demirer S; Dolgun A; Keceli HG
    J Clin Periodontol; 2016 Nov; 43(11):955-964. PubMed ID: 27396428
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of enamel matrix proteins on the periodontal connective tissue-material interface after wound healing.
    Craig RG; Kallur SP; Inoue M; Rosenberg PA; LeGeros RZ
    J Biomed Mater Res A; 2004 Apr; 69(1):180-7. PubMed ID: 14999766
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A multi-centre randomized controlled clinical trial on the treatment of intra-bony defects with enamel matrix derivatives/synthetic bone graft or enamel matrix derivatives alone: results after 12 months.
    Meyle J; Hoffmann T; Topoll H; Heinz B; Al-Machot E; Jervøe-Storm PM; Meiss C; Eickholz P; Jepsen S
    J Clin Periodontol; 2011 Jul; 38(7):652-60. PubMed ID: 21564156
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Enamel matrix protein derivative and/or synthetic bone substitute for the treatment of mandibular class II buccal furcation defects. A 12-month randomized clinical trial.
    Queiroz LA; Santamaria MP; Casati MZ; Ruiz KS; Nociti F; Sallum AW; Sallum EA
    Clin Oral Investig; 2016 Sep; 20(7):1597-606. PubMed ID: 26556577
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Five-year clinical results for treatment of intrabony defects with EMD, guided tissue regeneration and open-flap debridement: a case series.
    Mitani A; Takasu H; Horibe T; Furuta H; Nagasaka T; Aino M; Fukuda M; Fujimura T; Mogi M; Noguchi T
    J Periodontal Res; 2015 Feb; 50(1):123-30. PubMed ID: 24815103
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Influence of biphasic calcium phosphate surfaces coated with Enamel Matrix Derivative on vertical bone growth in an extra-oral rabbit model.
    Wen B; Li Z; Nie R; Liu C; Zhang P; Miron RJ; Dard MM
    Clin Oral Implants Res; 2016 Oct; 27(10):1297-1304. PubMed ID: 26689728
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A comparative analysis of bone formation induced by human demineralized freeze-dried bone and enamel matrix derivative in rat calvaria critical-size bone defects.
    Intini G; Andreana S; Buhite RJ; Bobek LA
    J Periodontol; 2008 Jul; 79(7):1217-24. PubMed ID: 18597604
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A clinical comparison of a bovine-derived xenograft used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects in humans.
    Scheyer ET; Velasquez-Plata D; Brunsvold MA; Lasho DJ; Mellonig JT
    J Periodontol; 2002 Apr; 73(4):423-32. PubMed ID: 11990444
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A retrospective case series comparing the use of demineralized freeze-dried bone allograft and freeze-dried bone allograft combined with enamel matrix derivative for the treatment of advanced osseous lesions.
    Rosen PS; Reynolds MA
    J Periodontol; 2002 Aug; 73(8):942-9. PubMed ID: 12211505
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical evaluation of demineralized freeze-dried bone allograft with and without enamel matrix derivative for the treatment of periodontal osseous defects in humans.
    Hoidal MJ; Grimard BA; Mills MP; Schoolfield JD; Mellonig JT; Mealey BL
    J Periodontol; 2008 Dec; 79(12):2273-80. PubMed ID: 19053917
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of autogenous cortical bone particulate in conjunction with enamel matrix derivative in the treatment of periodontal intraosseous defects.
    Guida L; Annunziata M; Belardo S; Farina R; Scabbia A; Trombelli L
    J Periodontol; 2007 Feb; 78(2):231-8. PubMed ID: 17274711
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Application of biological factor in cementum regeneration].
    Wang J; Tian ZL; Liu YP; Liu ZH; Sun HC; Ni SL
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2019 Aug; 54(8):568-572. PubMed ID: 31378037
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Bone Regenerative Potential of Enamel Matrix Protein in the Circumferential Defect Around a Dental Implant.
    Lim HC; Lee JS; Jung UW; Choi SH
    Implant Dent; 2016 Apr; 25(2):179-85. PubMed ID: 26836128
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The use of bovine porous bone mineral in combination with enamel matrix proteins or with an autologous fibrinogen/fibronectin system in the treatment of intrabony periodontal defects in humans.
    Lekovic V; Camargo PM; Weinlaender M; Vasilic N; Djordjevic M; Kenney EB
    J Periodontol; 2001 Sep; 72(9):1157-63. PubMed ID: 11577946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.